The Next Generation Diabetes Therapy And Drug Delivery Market is expected to register a CAGR of 16.0% from 2025 to 2031, with a market size expanding from US$ XX million in 2024 to US$ XX Million by 2031.
The report is segmented by Next Generation Diabetes Therapy And Drug Delivery Market By Product Type (Inhalable Insulin, Oral Insulin, Insulin Patches, CGM Systems, Artificial Pancreas); Indication (Type 1 Diabetes, Type 2 Diabetes); End-User (Diagnostics/Clinics, ICUs, Home Healthcare) , and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America). The global analysis is further broken-down at regional level and major countries. The Report Offers the Value in USD for the above analysis and segments.
Purpose of the ReportThe report Next Generation Diabetes Therapy And Drug Delivery Market by The Insight Partners aims to describe the present landscape and future growth, top driving factors, challenges, and opportunities. This will provide insights to various business stakeholders, such as:
- Technology Providers/Manufacturers: To understand the evolving market dynamics and know the potential growth opportunities, enabling them to make informed strategic decisions.
- Investors: To conduct a comprehensive trend analysis regarding the market growth rate, market financial projections, and opportunities that exist across the value chain.
- Regulatory bodies: To regulate policies and police activities in the market with the aim of minimizing abuse, preserving investor trust and confidence, and upholding the integrity and stability of the market.
Next Generation Diabetes Therapy And Drug Delivery Market Segmentation
Product Type- Inhalable Insulin
- Oral Insulin
- Insulin Patches
- CGM Systems
- Artificial Pancreas
- Type 1 Diabetes
- Type 2 Diabetes
- Diagnostics/Clinics
- ICUs
- Home Healthcare
- North America
- Europe
- Asia-Pacific
- South and Central America
- Middle East and Africa
Strategic Insights
Next Generation Diabetes Therapy And Drug Delivery Market Growth Drivers- Rising Diabetic Population: World figures are now estimated to be experiencing a gradual increase in diabetes prevalence, with the likelihood of reaching 700 million living with diabetes by 2045. This increase in patients who suffer from diabetes straightaway increases the demand for next generation diabetes therapy and drug delivery products , respectively.
- Patient empowerment:There is a conscious awareness among patients that if they are to control diabetes well, there should be monitoring of insulin levels always. Consequently, the demand for next generation diabetes therapy and drug delivery products has risen as patients see an increased need to be more in control of their own health.
- Rising demand for non-invasive solutions -Because non-invasive therapies are more convenient and cause less discomfort than traditional injectable methods, there is a rising preference for them. It is anticipated that this tendency would have a substantial impact on market growth as patients look for simpler management options.
- Integration of Digital Health: The COVID-19 pandemic hastened the uptake of digital health technologies, including as remote monitoring programs and telemedicine, which are now essential for the treatment of chronic illnesses like diabetes. One important contributing factor is the rise in type 2 diabetes cases worldwide. Urbanization, bad diets, sedentary lifestyles, and aging populations are some of the factors behind this rise.
- Technological Advancements and Innovations: Diabetes care is changing as a result of innovations including insulin patches, inhalable insulin, smart insulin pens, artificial pancreas devices, and continuous glucose monitoring (CGM) systems. The goal of these technologies is to improve patient compliance and comfort by offering less intrusive treatment options.
- Shift Towards Connected and Automated Devices: Integration of mobile applications, wireless connectivity, and artificial intelligence determines the real landscape in hext generation diabetes therapy and drug delivery. Connected devices help in better management of data analysis, promote patient involvement in care, and reinforce collaboration between patients and healthcare providers.
- Continuous Glucose Monitoring:Non-invasive technologies are emerging that would relate to blood glucose monitoring technologies, where there would no longer be a need for pricking the fingers. Companies investing in development and research into such technologies may gain considerable market share as patients would look for less painful procedures.
- Electronic Health Records Integration: The integration of diabetic data into electronic health records (EHRs) improves patient information accessibility for healthcare practitioners, enabling more informed decisions about tailored treatment plans. Such a factor has aided the overall market growth in the recent past and is expected to follow a similar trend during the forecast period.
- Rising Awareness of Diabetes Management:There is also a growing awareness about diabetes management, especially in prediabetics, hence the increasing demand for next generation diabetes therapy and drug delivery products. Educational activities toward the benefits of monitoring their health can further increase demand. Such a factor is expected to aid the overall next generation diabetes therapy and drug delivery products market during the forecast period.
Market Report Scope
Key Selling Points
- Comprehensive Coverage: The report comprehensively covers the analysis of products, services, types, and end users of the Next Generation Diabetes Therapy And Drug Delivery Market, providing a holistic landscape.
- Expert Analysis: The report is compiled based on the in-depth understanding of industry experts and analysts.
- Up-to-date Information: The report assures business relevance due to its coverage of recent information and data trends.
- Customization Options: This report can be customized to cater to specific client requirements and suit the business strategies aptly.
The research report on the Next Generation Diabetes Therapy And Drug Delivery Market can, therefore, help spearhead the trail of decoding and understanding the industry scenario and growth prospects. Although there can be a few valid concerns, the overall benefits of this report tend to outweigh the disadvantages.
REGIONAL FRAMEWORK
Have a question?
Mrinal
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
In Europe, the UK held the second largest share in 2023.
Diagnostics/Clinics segment accounted for the largest share in 2023 and is expected to retain its dominance during the forecast period
Continuous Glucose Monitoring
The Next Generation Diabetes Therapy And Drug Delivery Market is estimated to witness a CAGR of 16.0% from 2023 to 2031
Rising Diabetic Population
North America held the largest share in 2023 and is expected to retain its dominance during the forecast period
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Next Generation Diabetes Therapy And Drug Delivery Market - By Product Type
1.3.2 Next Generation Diabetes Therapy And Drug Delivery Market - By Indication
1.3.3 Next Generation Diabetes Therapy And Drug Delivery Market - By End-User
1.3.4 Next Generation Diabetes Therapy And Drug Delivery Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET - GLOBAL MARKET ANALYSIS
6.1. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY - GLOBAL MARKET OVERVIEW
6.2. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY - GLOBAL MARKET AND FORECAST TO 2028
6.3. MARKET POSITIONING/MARKET SHARE
7. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET - REVENUE AND FORECASTS TO 2028 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. INHALABLE INSULIN
7.3.1. Overview
7.3.2. Inhalable Insulin Market Forecast and Analysis
7.4. ORAL INSULIN
7.4.1. Overview
7.4.2. Oral Insulin Market Forecast and Analysis
7.5. INSULIN PATCHES
7.5.1. Overview
7.5.2. Insulin Patches Market Forecast and Analysis
7.6. CGM SYSTEMS
7.6.1. Overview
7.6.2. CGM Systems Market Forecast and Analysis
7.7. ARTIFICIAL PANCREAS
7.7.1. Overview
7.7.2. Artificial Pancreas Market Forecast and Analysis
8. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET - REVENUE AND FORECASTS TO 2028 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. TYPE 1 DIABETES
8.3.1. Overview
8.3.2. Type 1 Diabetes Market Forecast and Analysis
8.4. TYPE 2 DIABETES
8.4.1. Overview
8.4.2. Type 2 Diabetes Market Forecast and Analysis
9. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET - REVENUE AND FORECASTS TO 2028 - END-USER
9.1. OVERVIEW
9.2. END-USER MARKET FORECASTS AND ANALYSIS
9.3. DIAGNOSTICS/CLINICS
9.3.1. Overview
9.3.2. Diagnostics/Clinics Market Forecast and Analysis
9.4. ICUS
9.4.1. Overview
9.4.2. ICUs Market Forecast and Analysis
9.5. HOME HEALTHCARE
9.5.1. Overview
9.5.2. Home Healthcare Market Forecast and Analysis
10. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET REVENUE AND FORECASTS TO 2028 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Next Generation Diabetes Therapy And Drug Delivery Market Overview
10.1.2 North America Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis
10.1.3 North America Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Product Type
10.1.4 North America Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Indication
10.1.5 North America Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By End-User
10.1.6 North America Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Countries
10.1.6.1 United States Next Generation Diabetes Therapy And Drug Delivery Market
10.1.6.1.1 United States Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.1.6.1.2 United States Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.1.6.1.3 United States Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.1.6.2 Canada Next Generation Diabetes Therapy And Drug Delivery Market
10.1.6.2.1 Canada Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.1.6.2.2 Canada Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.1.6.2.3 Canada Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.1.6.3 Mexico Next Generation Diabetes Therapy And Drug Delivery Market
10.1.6.3.1 Mexico Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.1.6.3.2 Mexico Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.1.6.3.3 Mexico Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.2. EUROPE
10.2.1 Europe Next Generation Diabetes Therapy And Drug Delivery Market Overview
10.2.2 Europe Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis
10.2.3 Europe Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Product Type
10.2.4 Europe Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Indication
10.2.5 Europe Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By End-User
10.2.6 Europe Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Next Generation Diabetes Therapy And Drug Delivery Market
10.2.6.1.1 Germany Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.2.6.1.2 Germany Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.2.6.1.3 Germany Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.2.6.2 France Next Generation Diabetes Therapy And Drug Delivery Market
10.2.6.2.1 France Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.2.6.2.2 France Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.2.6.2.3 France Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.2.6.3 Italy Next Generation Diabetes Therapy And Drug Delivery Market
10.2.6.3.1 Italy Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.2.6.3.2 Italy Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.2.6.3.3 Italy Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.2.6.4 Spain Next Generation Diabetes Therapy And Drug Delivery Market
10.2.6.4.1 Spain Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.2.6.4.2 Spain Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.2.6.4.3 Spain Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.2.6.5 United Kingdom Next Generation Diabetes Therapy And Drug Delivery Market
10.2.6.5.1 United Kingdom Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.2.6.5.2 United Kingdom Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.2.6.5.3 United Kingdom Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Next Generation Diabetes Therapy And Drug Delivery Market Overview
10.3.2 Asia-Pacific Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis
10.3.3 Asia-Pacific Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By End-User
10.3.6 Asia-Pacific Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Next Generation Diabetes Therapy And Drug Delivery Market
10.3.6.1.1 Australia Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.3.6.1.2 Australia Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.3.6.1.3 Australia Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.3.6.2 China Next Generation Diabetes Therapy And Drug Delivery Market
10.3.6.2.1 China Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.3.6.2.2 China Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.3.6.2.3 China Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.3.6.3 India Next Generation Diabetes Therapy And Drug Delivery Market
10.3.6.3.1 India Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.3.6.3.2 India Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.3.6.3.3 India Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.3.6.4 Japan Next Generation Diabetes Therapy And Drug Delivery Market
10.3.6.4.1 Japan Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.3.6.4.2 Japan Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.3.6.4.3 Japan Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.3.6.5 South Korea Next Generation Diabetes Therapy And Drug Delivery Market
10.3.6.5.1 South Korea Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.3.6.5.2 South Korea Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.3.6.5.3 South Korea Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Next Generation Diabetes Therapy And Drug Delivery Market Overview
10.4.2 Middle East and Africa Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis
10.4.3 Middle East and Africa Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By End-User
10.4.6 Middle East and Africa Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Next Generation Diabetes Therapy And Drug Delivery Market
10.4.6.1.1 South Africa Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.4.6.1.2 South Africa Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.4.6.1.3 South Africa Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.4.6.2 Saudi Arabia Next Generation Diabetes Therapy And Drug Delivery Market
10.4.6.2.1 Saudi Arabia Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.4.6.2.2 Saudi Arabia Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.4.6.2.3 Saudi Arabia Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.4.6.3 U.A.E Next Generation Diabetes Therapy And Drug Delivery Market
10.4.6.3.1 U.A.E Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.4.6.3.2 U.A.E Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.4.6.3.3 U.A.E Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Next Generation Diabetes Therapy And Drug Delivery Market Overview
10.5.2 South and Central America Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis
10.5.3 South and Central America Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By End-User
10.5.6 South and Central America Next Generation Diabetes Therapy And Drug Delivery Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Next Generation Diabetes Therapy And Drug Delivery Market
10.5.6.1.1 Brazil Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.5.6.1.2 Brazil Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.5.6.1.3 Brazil Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.5.6.2 Argentina Next Generation Diabetes Therapy And Drug Delivery Market
10.5.6.2.1 Argentina Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.5.6.2.2 Argentina Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.5.6.2.3 Argentina Next Generation Diabetes Therapy And Drug Delivery Market by End-User
10.5.6.3 Chile Next Generation Diabetes Therapy And Drug Delivery Market
10.5.6.3.1 Chile Next Generation Diabetes Therapy And Drug Delivery Market by Product Type
10.5.6.3.2 Chile Next Generation Diabetes Therapy And Drug Delivery Market by Indication
10.5.6.3.3 Chile Next Generation Diabetes Therapy And Drug Delivery Market by End-User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. NEXT GENERATION DIABETES THERAPY AND DRUG DELIVERY MARKET, KEY COMPANY PROFILES
12.1. ABBOTT LABORATORIES
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. MEDTRONIC, INC.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. SANOFI
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. NOVO NORDISK
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. MANNKIND CORPORATION
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. ENTERIS BIOPHARMA
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. DEXCOM, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. SENSEONICS HOLDING, INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. MEDTECH
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. JOHNSON AND JOHNSON
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
1. Abbott Laboratories
2. Medtronic, Inc.
3. Sanofi
4. Novo Nordisk
5. MannKind Corporation
6. Enteris BioPharma
7. Dexcom, Inc.
8. Senseonics Holding, Inc.
9. Medtech
10. Johnson and Johnson
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For